Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adaptix is a UK-based medical imaging innovator that is transforming radiology through the development of portable, low-dose 3D digital tomosynthesis systems. The company's core technology is a patented Flat Panel X-ray Source (FPS) that digitizes the X-ray source, enabling fast 3D imaging with no moving parts at the point of care. Its flagship product, the Ortho350, is an FDA-cleared and CE-certified orthopedic extremity imaging system that provides CT-like multi-slice visualization at a fraction of the cost, space, and radiation dose of traditional CT scanners. Adaptix also serves the veterinary market with its VetSA3D system and is expanding into dental, chest imaging, and industrial non-destructive testing (NDT) applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adaptix.